Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Relay Therapeutics, Inc. (RLAY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/01/2023 |
4/A
| Rahmer Peter (See remarks) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 1,657 shares
@ $11.16, valued at
$18.5k
|
|
| 06/01/2023 |
4/A
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 2,012 shares
@ $11.16, valued at
$22.5k
|
|
| 06/01/2023 |
4/A
| Bergstrom Donald A (President, R&D) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 2,850 shares
@ $11.16, valued at
$31.8k
|
|
| 06/01/2023 |
4/A
| Adams Brian (Chief Legal Officer) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 1,936 shares
@ $11.16, valued at
$21.6k
|
|
| 06/09/2021 |
4/A
| Catinazzo Thomas (Senior Vice President, Finance) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 22,500 shares
@ $35, valued at
$787.5k
Exercised 22,500 options to buy
@ $4.12, valued at
$92.7k
|
|
| 01/14/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
|
|